Evidence map›Paper›PMID 34834403›Full record

ArticleJournal of personalized medicine2021

Impact of Updating Pharmacogenetic Results: Lessons Learned from the PREDICT Program.

Michelle Liu, Sara L Van Driest, Cindy L Vnencak-Jones, Leigh Ann G Saucier, Bartholomew P Roland, Cheryl L Gatto, Shari L Just, Asli O Weitkamp, Josh F Peterson

Open access · goldAbstract read
In one paragraph

Article in Journal of personalized medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Genomic medicine for liver disease.Hepatology (Baltimore, Md.) · 2022
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Michelle LiuDepartment of Pharmacy, Vanderbilt University Medical Center, Nashville, TN 37232, USA.ORCID 0000-0001-6925-7064
Sara L Van DriestDepartment of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Cindy L Vnencak-JonesDepartment of Pediatrics, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Leigh Ann G SaucierVanderbilt Institute for Clinical & Translational Research, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Bartholomew P RolandVanderbilt Institute for Clinical & Translational Research, Vanderbilt University Medical Center, Nashville, TN 37232, USA.ORCID 0000-0002-9033-9942
Cheryl L GattoVanderbilt Institute for Clinical & Translational Research, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Shari L JustHealth IT Decision Support and Knowledge Engineering, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Asli O WeitkampDepartment of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Josh F PetersonDepartment of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Vanderbilt University Medical Center · US

Funding

Vanderbilt Institute for Clinical and Translational Research (VICTR) -Identifying correlates of functional immunity in SARS-CoV-2 convalescent plasmaUL1TR002243 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Paul A. Harris, Wesley H Self · 2017 to 2026
$130.7M
Integrated, Individualized, and Intelligent Prescribing (I3P) Clinical Trial NetworkU01HG010232 · NHGRI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI CAVANAUGH, KERRI, PETERSON, JOSEPH F. · 2018 to 2024
$8.2M
Integrated, Individualized, Intelligent Prescribing (I3P)U01HG007253 · NHGRI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI LEVY, MIA A., PETERSON, JOSEPH F. · 2014 to 2018
$4.6M
NCATS NIH HHS UL1TR002243NHGRI NIH HHS U01HG007253NHGRI NIH HHS U01HG010232
6 · The paper itself

Abstract

Pharmacogenomic (PGx) evidence for selective serotonin reuptake inhibitors (SSRIs) continues to evolve. For sites offering testing, maintaining up-to-date interpretations and implementing new clinical decision support (CDS) driven by existing results creates practical and technical challenges. Vanderbilt University Medical Center initiated panel testing in 2010, added

Indexed as

personalized medicinepharmacogeneticspharmacogenomicsprecision medicinereinterpretationreprocessingSSRIs

Identifiers

PMID34834403
PMCPMC8617828
OpenAlexW3205171759

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.